Moneycontrol
SENSEX NIFTY
YOU ARE HERE > MONEYCONTROL > MARKETS > PHARMACEUTICALS > News - Aurobindo Pharma

Aurobindo Pharma

BSE: 524804|NSE: AUROPHARMA|ISIN: INE406A01037|SECTOR: Pharmaceuticals
SET ALERT
|
ADD TO PORTFOLIO
|
WATCHLIST
LIVE
BSE
Nov 20, 16:00
706.65
-1.05 (-0.15%)
VOLUME 124,463
LIVE
NSE
Nov 20, 15:59
706.45
-2.35 (-0.33%)
VOLUME 1,652,210
News on Aurobindo Pharma
Select Year: 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2000-2005
Aurobindo Pharma Q2 net up 29% at Rs 780.97 cr 

8.50 am | 10 Nov 2017 |  Source: PTI

The company had posted a net profit of Rs 605.55 crore for the corresponding period of the previous fiscal, Aurobindo Pharma said in a BSE filing....

Aurobindo Pharma's board declares interim dividend

10.47 pm | 09 Nov 2017 |  Source: Moneycontrol.com

Aurobindo Pharma has informed that the Board of Directors of the Company at its meeting held on November 09, 2017, has considered & approved interim d...

Sell M&M Financial; buy Sun Pharma, Tata Steel, Voltas, Page Industries: Sudarshan Sukhani 

9.37 am | 09 Nov 2017 |  Source: CNBC-TV18

Sudarshan Sukhani of s2analytics.com is of the view that one can sell Mahindra & Mahindra Financial Services and buy Sun Pharmaceutical Industries, Ta...

Stocks in the news: Tata Motors, Rel Infra, Muthoot Finance, JK Lakshmi, GSFC, Voltas 

8.29 am | 09 Nov 2017 |  Source: CNBC-TV18

Tata Motors | Aurobindo Pharma | Reliance Infrastructure | Indian Hotels | JK Lakshmi Cement | VA Tech Wabag | Weslpun India | Triveni Engineering | F...

News as-it-happened: Parliamentary panel quizzes FinMin officials on note ban impact

7.00 am | 09 Nov 2017 |  Source: Moneycontrol.com

This blog will keep track of key global and local developments impacting business and markets through the day. Important local and global political de...

Aurobindo Pharma Q2 profit seen up 15% to Rs 696 cr, operating margin may grow 110 bps 

5.26 pm | 08 Nov 2017 |  Source: CNBC-TV18

EBITDA (earnings before interest, tax, depreciation and amortisation) may increase 15.6 percent year-on-year to Rs 1,074.4 crore and margin may expand...

Buy Aurobindo Pharma, Lupin, Balrampur Chini: Rajat Bose 

11.30 am | 07 Nov 2017 |  Source: CNBC-TV18

Rajat Bose of rajatkbose.com recommends buying Aurobindo Pharma, Lupin and Balrampur Chini....

Top buy & sell ideas by Ashwani Gujral, Mitessh Thakkar & Prakash Gaba for November 6 

8.36 am | 06 Nov 2017 |  Source: CNBC-TV18

Ashwani Gujral of ashwanigujral.com suggests buying Steel Authority of India with a stop loss of Rs 84, target of Rs 96, a buy on BF Utilities with a ...

Top 5 stocks in the coming week which could give up to 5-12% return in November

10.04 am | 04 Nov 2017 |  Source: Moneycontrol.com

Aurobindo Pharma, L&T, Karnataka Bank, Indian Bank, REC Ltd, NTPC, DLF and Sun TV are looking attractive on technical setup....

Buy Aurobindo Pharma, Castrol India, Jain Irrigation Systems, Indraprastha Gas: Chandan Taparia 

10.11 am | 03 Nov 2017 |  Source: CNBC-TV18

Chandan Taparia of Motilal Oswal Securities recommends buying Aurobindo Pharma, Castrol India, Jain Irrigation Systems and Indraprastha Gas....

Aurobindo Pharma gains 4% on USFDA nod

10.01 am | 02 Nov 2017 |  Source: Moneycontrol.com

The company's board meeting will be held on November 09 to consider and approve the un-audited financial results of the company for the second qua...

Like Aurobindo Pharma, JSW Energy: Prakash Gaba 

4.33 pm | 27 Oct 2017 |  Source: CNBC-TV18

Prakash Gaba of prakashgaba.com likes Aurobindo Pharma for target of Rs 790 and JSW Energy for target of Rs 90....

Buy Aurobindo Pharma, Wockhardt, Suzlon Energy: CA Rudramurthy BV 

12.49 pm | 26 Oct 2017 |  Source: CNBC-TV18

CA Rudramurthy BV, Research Head at Vachana Investments recommends buying Aurobindo Pharma, Wockhardt and Suzlon Energy....

After PM Modi's attack, Congress dares BJP to probe allegations against Vadra

8.50 pm | 17 Oct 2017 |  Source: Moneycontrol.com

Here’s wishing you a happy and prosperous Dhanteras. This blog will keep track of key global and local developments impacting business and markets t...

Buy Aurobindo Pharma, BPCL: Mitessh Thakkar 

3.40 pm | 17 Oct 2017 |  Source: CNBC-TV18

Mitessh Thakkar of miteshthacker.com recommends buying Aurobindo Pharma and BPCL....

Buy Aurobindo Pharma, Ashok Leyland, Century Textiles: Gaurav Bissa 

1.05 pm | 17 Oct 2017 |  Source: CNBC-TV18

Gaurav Bissa of LKP Securities recommends buying Aurobindo Pharma, Ashok Leyland and Century Textiles and Industries....

Aurobindo Pharma gets USFDA nod for heartburn drug

12.21 pm | 17 Oct 2017 |  Source: PTI

In a BSE filing, Aurobindo Pharma said it "has received final approval from the US Food and Drug Administration (USFDA) to manufacture Esomeprazole Ma...

Aurobindo Pharma rises 2% on USFDA final nod for Esomeprazole capsules

11.18 am | 17 Oct 2017 |  Source: Moneycontrol.com

The company has received final approval from the US Food & Drug Administration (USFDA) to manufacture Esomeprazole Magnesium Delayed-Release Capsules ...

Aurobindo Pharma receives USFDA approval for Esomeprazole Magnesium DR capsules OTC

11.09 am | 17 Oct 2017 |  Source: Moneycontrol.com

Aurobindo Pharma Limited is pleased to announce that the company has received final approval from the US Food & Drug Administration (USFDA) to manufac...

Buy Maruti, Ashok Leyland, Auro Pharma, Federal Bank; sell Indiabulls Real Estate: Sudarshan Sukhani 

10.59 am | 17 Oct 2017 |  Source: CNBC-TV18

Sudarshan Sukhani of s2analytics.com is of the view that one can buy Maruti Suzuki, Ashok Leyland, Aurobindo Pharma, Federal Bank, DHFL and JSW Steel ...

1 2 3 4
Quick Links for Aurobindo Pharma
Explore Moneycontrol
Stocks     A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z | Others
Mutual Funds     A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z
Copyright © e-Eighteen.com Ltd. All rights reserved. Reproduction of news articles, photos, videos or any other content in whole or in part in any form or medium without express written permission of moneycontrol.com is prohibited.